TELOMIR PHARMACEUTICALS SELECTS LINICAL TO ADVANCE FDA-CLEARED PHASE 1/2 CLINICAL TRIAL OF TELOMIR-ZN IN TRIPLE-NEGATIVE BREAST CANCER

Reuters · 1d ago

Please log in to view news